期刊文献+

颞下颌关节紊乱综合征关节液白细胞介素1活性及其临床意义 被引量:6

INTERLEUKIN-1 ACTIVITY IN SYNOVIAL FLUIDS OF TEMPOROMANDIBULAR JOINT DISTURBANCE SYNDROME
下载PDF
导出
摘要 采用传代淋巴细胞株LBRM33-IA 5和HT-2,检测了36例颞下颌关节紊乱综合征(TMJDS)关节液中IL-1活性,发现TMJDS关节液中检测到IL-1活性,且器质性改变类患者关节液IL-1活性明显高于肌肉功能紊乱类及结构紊乱类。结果提示,IL-1参与了TMJDS关节组织的病理破坏过程。 Using murine T cell close LBRM33-IA5 and HT-2, interleukin 1 (IL-1) biological activity insynovial fluids of the patients with Temporomandibular Joint Disturbance Syndrome (TMJDS) wastested. The results demonstrate that IL-1 activity is much higher in the cases with TMJ degenerativechanges than the cases with Masticatory Muscle Disorder and the cases with TMJ Disc Displacement.The findings suggest that IL-1 and IL-1 inhibitors present in synovial fluids of TMJDS, and contributeto joint destruction.
出处 《北京医科大学学报》 CSCD 1993年第6期403-405,共3页 Journal of Peking University(Health Sciences)
基金 国家教委博士点专项基金
关键词 颞下颌关节 综合征 关节液 Temporomandibular joint Synovial fluid Cytokine
  • 相关文献

参考文献6

  • 1傅开元,国外医学口腔医学分册,1993年,20卷,129页
  • 2陈慰峰,1992年
  • 3谷志远,中华口腔医学杂志,1991年,26卷,300页
  • 4马绪臣,中华口腔医学杂志,1985年,20卷,208页
  • 5马绪臣,中华医学杂志,1985年,65卷,270页
  • 6傅开元,中华口腔医学杂志

同被引文献31

  • 1谷志远,孙永良.肿瘤坏死因子在颞下颌关节紊乱综合征中的作用[J].中华口腔医学杂志,1993,28(4):203-205. 被引量:8
  • 2傅开元,马绪臣,张震康,庞学文,陈慰峰.颞下颌关节紊乱综合征关节液中肿瘤坏死因子活性的检测[J].中华口腔医学杂志,1994,29(5):269-271. 被引量:4
  • 3傅开元,马绪臣,张震康,庞学文,陈慰峰.颞下颌关节紊乱综合征关节液IL-6活性及其临床初步探讨[J].中华口腔医学杂志,1995,30(4):242-244. 被引量:5
  • 4张娟,张志光.颞下颌关节紊乱病实验动物模型的研究进展[J].国外医学(口腔医学分册),2005,32(6):446-448. 被引量:3
  • 5[1]Milam SB,Schmitz JP.Molecular biology of temporomandbular joint disorder.J Oral Maxillofac Surg,1995,53:1448-1454.
  • 6[2]Kubota E,Imamura H,Kubota T,et al.Interleukin 1β and stromelysin(MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandbular joint.J Oral Maxillofac Surg,1997,55:20-27.
  • 7[4]Truelove EL,Sommers EE,LeResche L,et al.Clinical diagnostic criteria for TMD.New classification permits multiple diagnoses.J Am Dent Assoc,1992,123:47-54.
  • 8[6]Alstergren P,Alstergren B,Alstergren A,et al.Co-variation of nuropeptide Y,Calcitonin gene-related peptide,substance P and nurokinin A in joint fluid from patients with temporomandibular joint arthritis.Arch Oral Biol,1995,40:127-135.
  • 9[7]Holmlund A,Ekblom A,Hansson P,et al.Concentration of nuropeptides substance P,nurokinin A,calcitonin gene-related peptide,nuropeptide Y,and vasocative intestinal ploypeptide in synovial fluid of human temporomandibular joint.Int J Oral Surg,1991,20:228-231.
  • 10[9]Kubota E,Kubota T,Matsumoto J,et al.Synovial fluid cytokines and proteinases as markers of temporomandbular joint disease.J Oral Maxillofac Surg,1998,56:192-198.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部